Glaxo Singled Out in China Probe, Smith Says

July 24 (Bloomberg) -- Andy Smith, chief investment officer at Mann Bioinvest Ltd., talks about the Chinese probe of GlaxoSmithKline Plc over allegations of bribery and corruption. He speaks with Mark Barton and Anna Edwards on Bloomberg Television's "Countdown." (Source: Bloomberg)

How Long Will Chinese Growth Rates Decline For?
56:54 - China’s foreign-exchange reserves shrank to the smallest since 2012, indicating that the central bank sold dollars as the yuan’s retreat to a five-year low exacerbated depreciation pressure. UBS Head of Global Asset Allocation Mads Pedersen discusses with Bloomberg’s Manus Cranny and Anna Edwards on “Countdown.”
  • Twitter: Bloomberg West (Full Show 02/05)
  • Bloomberg Best: Mark Hurd
  • Will Mayer’s Turnaround Plan Work for Yahoo?